文献速递白内障与屈光手术

血清补体C3水平与年龄相关性白内障的关联

Association Between Serum Complement C3 Levels and Age-Related Cataract.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

研究纳入492例年龄相关性白内障(ARC)患者和466名正常对照,采用免疫比浊法测定血清补体C3水平。ARC组血清C3均值(100.97 ± 18.22 mg/dL)显著低于对照组(123.27 ± 22.51 mg/dL)(P < 0.001),logistic回归显示补体C3与ARC相关(OR = 0.924,95%CI = 0.913-0.935)。作者认为C3可能参与ARC的病理机制。

要点

  • ARC组血清C3均值100.97 ± 18.22 mg/dL,低于对照组的123.27 ± 22.51 mg/dL(P < 0.001)。
  • 按性别和年龄分层比较,ARC组血清C3水平均低于对照组。
  • 核性ARC亚组血清C3均值最低(98.63 ± 18.76 mg/dL),三型间差异显著(P = 0.037)。

核心结论

  • ARC患者血清C3水平较低,且与ARC的发生/发展相关,提示C3可能参与ARC的病理机制。

研究设计与样本

  • 研究连续纳入2014年6月至2017年5月复旦大学附属眼耳鼻喉科医院眼科与视觉科学系的492例ARC患者和466名正常对照。
  • 采用免疫比浊法测定血清C3水平,并收集眼压、视力、中央角膜厚度、眼轴长度、垂直杯盘比等临床信息及人口学信息。
  • 按性别和年龄将ARC受试者分为女性(50-60岁、61-70岁、71岁以上)和男性(50-60岁、61-70岁、71岁以上)亚组。

主要发现

  • ARC组血清C3均值100.97 ± 18.22 mg/dL,显著低于对照组123.27 ± 22.51 mg/dL(t = 16.888,P < 0.001)。
  • 按性别和年龄分层比较,ARC组与对照组之间血清C3水平的比较也观察到类似结果。
  • 核性ARC亚组血清C3均值最低(98.63 ± 18.76 mg/dL),依次为皮质性ARC亚组(102.26 ± 18.04 mg/dL)和后囊下ARC亚组(103.80 ± 17.20 mg/dL),差异显著(P = 0.037)。
  • logistic回归分析显示补体C3与ARC相关(OR = 0.924,95%CI = 0.913-0.935)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The serum complement component 3 (C3) concentration and clinical characteristics of age-related cataract (ARC) subjects were analyzed to evaluate whether serum C3 levels are correlated with ARC. METHODS: A total of 492 ARC patients and 466 normal subjects from the Department of Ophthalmology and Visual Science, Eye and ENT Hospital of Fudan University, Shanghai, China, were consecutively recruited into this study between June 2014 and May 2017. Immunoturbidimetry was used to measure the serum C3 levels. Clinical information (intraocular pressure, visual acuity, central corneal thickness, axial length, vertical cup/disc ratio) and demographic information were obtained. Based on sex and age, the ARC subjects were categorized into female (50-60 years, 61-70 years, and 71+ years) and male (50-60 years, 61-70 years, and 71+ years) subgroups. RESULTS: The mean serum C3 level was significantly lower in the ARC group (100.97 ± 18.22 mg/dL) in comparison to the control group (123.27 ± 22.51 mg/dL) (t = 16.888, P < 0.001). A similar result was also observed when the serum C3 levels were compared between the ARC and control groups with respect to sex and age. The mean serum C3 level was lowest in the nuclear ARC subgroup (98.63 ± 18.76 mg/dL) followed by the cortical ARC subgroup (102.26 ± 18.04 mg/dL) and the posterior subcapsular ARC subgroup (103.80 ± 17.20 mg/dL), and the differences were significant (P = 0.037). Logistic regression analyses revealed that complement C3 (odds ratio [OR] = 0.924, 95% confidence interval [CI] = 0.913-0.935) was associated with ARC. CONCLUSIONS: ARC patients have lower serum C3 levels, which were further demonstrated to be correlated with the onset/development of ARC. These findings suggest the involvement of C3 in the pathomechanisms of ARC.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Shao M, Li D, Teng J, et al. Association Between Serum Complement C3 Levels and Age-Related Cataract. Invest Ophthalmol Vis Sci. 2017. PMID: 28973339. doi:10.1167/iovs.17-22522

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。